Shandong Xinhua Pharmaceutical Company Limited
Shandong Xinhua Pharmaceutical Company Limited (HKSE: 719) is trading at HK$5.71, about ₹70 at today's HKD/INR rate, as of 29 Sep 2026, 4:08 AM ET, up 0.26% today. Indian residents can buy Shandong Xinhua Pharmaceutical from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$5.69
Today's high
HK$5.80
52 week low
HK$5.18
52 week high
HK$7.64
719 opened at HK$5.71, closed previously at HK$5.69, and has traded between HK$5.18 and HK$7.64 over the past 52 weeks.
About
Shandong Xinhua Pharmaceutical Company Limited develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People's Republic of China, the Americas, Europe, and internationally. The company offers antipyretic and analgesic, cardiovascular and cerebrovascular, anti-infective, and central nervous drugs under the Xinhua brand; and contract manufacturing services for active pharmaceutical ingredients and pharmaceutical intermediates, OTC, and generics. It also provides ibuprofen bulk pharmaceutical products; and prepared Chinese herbal medicine for decoction, traditional Chinese medicine, chemical bulk drugs, chemical preparations, chemical raw materials, antibiotics, biochemical medicines, anesthetics, anti-psychotic drugs, pharmaceutical precursor chemicals, protein assimilation preparations, peptide hormones, medical toxic drugs, etc. In addition, the company offers raw materials and intermediates; internet data services, internet sales, and internet information services for pharmaceuticals and medical devices; veterinary drugs and fodders; bulk pharmaceutical and intermediates; steroid system apis and intermediates; and chemical raw materials. Further, the company produces and sells chemical products; exports and imports goods and technologies; and designs medical projects. Additionally, it engages in the property management, nonresidential real estate leasing, and housing leasing activities; certification and import and export business; electrical equipment engineering; installation and testing of chemical equipment; and manufacture of mechanical and electrical equipment, nonstandard equipment, as well as production and hardware and electrical equipment, and electrical installations equipment and manufacture; and sale of controller switching equipment. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo, the People's Republic of China.
Key statistics
Avg. volume
1.81M
Market cap
HK$8.59B
P/E Ratio
45.14
Price-to-sales ratio
0.83
Enterprise value
CN¥7.46B
Free cash flow yield
5.52%
Debt-to-equity ratio
0.37
Return on equity
4.10%
ROIC
3.17%
Beta
-0.03
Dividend yield
1.07%
Last dividend
HK$0.17
Financial overview
Revenue
CN¥8.75B
Earnings per share
CN¥0.42
Free cash flow
CN¥418.13M
Net profit margin
2.54%
Gross margin
18.41%
EBITDA
CN¥988.87M
Revenue growth
3.41%
Similar securities
This is not an investment recommendation
How to buy Shandong Xinhua Pharmaceutical from India
Indian residents can buy Shandong Xinhua Pharmaceutical shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Shandong Xinhua Pharmaceutical and place an order
Find Shandong Xinhua Pharmaceutical by name or by its ticker, 719, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Shandong Xinhua Pharmaceutical trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Shandong Xinhua Pharmaceutical position in HKD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Shandong Xinhua Pharmaceutical from India
Trading and taxes when buying Shandong Xinhua Pharmaceutical from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Shandong Xinhua Pharmaceutical’s current yield is 1.07%.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Shandong Xinhua Pharmaceutical stock?
Yes. Shandong Xinhua Pharmaceutical (719) has been listed on the Hong Kong Stock Exchange since 2000, in the Medical - Pharmaceuticals industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Shandong Xinhua Pharmaceutical share cost in rupees?
One Shandong Xinhua Pharmaceutical share is HK$5.71 — about ₹70 at an HKD/INR rate of 12.25 on 28 Sep 2026. Both the Shandong Xinhua Pharmaceutical price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Shandong Xinhua Pharmaceutical from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Shandong Xinhua Pharmaceutical?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Shandong Xinhua Pharmaceutical shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Shandong Xinhua Pharmaceutical price. Paasa issues a capital-gains statement for your return.
Does Shandong Xinhua Pharmaceutical pay a dividend, and how is it taxed in India?
Yes. Shandong Xinhua Pharmaceutical pays a dividend and the current yield is 1.07%; the last declared dividend was HK$0.17 per share, about ₹2.11. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade Shandong Xinhua Pharmaceutical from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is Shandong Xinhua Pharmaceutical a Hong Kong SAR China company, and does that change how it is taxed?
Shandong Xinhua Pharmaceutical trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Shandong Xinhua Pharmaceutical trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Shandong Xinhua Pharmaceutical shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Shandong Xinhua Pharmaceutical holding, its cost and its closing value.
How do I sell Shandong Xinhua Pharmaceutical and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.